Advertisement

Use of integrated FDG-PET/CT in sarcoidosis

      Abstract

      We studied five patients with mediastinal lymph node enlargement suggestive of malignant lymphoma, lung cancer, or sarcoidosis. Integrated [18F]fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) was performed on all patients. Sarcoidosis can be a pitfall in PET/CT imaging, which may lead to false-positive results of malignancy. Increased FDG uptake in mediastinal lymph nodes is often comparable with malignant lymphoma or lymph node metastases. Histological confirmation of the lesions should be mandatory, except for patients in whom sarcoidosis can be accurately confirmed by other diagnostic methods.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lardinois D
        • Weder W
        • Hany TF
        • Kamel EM
        • Korom S
        • Seifert B
        • von Schulthess GK
        • Steinert HC
        Staging of non-small-lung cancer with integrated positron-emission tomography and computed tomography.
        N Engl J Med. 2003; 348: 2500-2507
        • Gupta NC
        • Frank AR
        • Dewan NA
        • Redepenning LS
        • Rothberg ML
        • Mailliard JA
        • Phalen JJ
        • Sunderland JJ
        • Frick MP
        Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-glucose.
        Radiology. 1992; 188: 442-444
        • Lowe VJ
        • Hoffmann JM
        • Delong DM
        • Patz EF
        • Coleman RE
        Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.
        J Nucl Med. 1994; 35: 1771-1776
        • Lowe VJ
        • Duhaylongsod FG
        • Patz EF
        • Delong DM
        • Hoffmann JM
        • Wolfe WG
        • Coleman RE
        Pulmonary abnormalities and PET data analysis: a retrospective study.
        Radiology. 1997; 202: 435-439
        • Lowe VJ
        • Fletcher JW
        • Gobar L
        • Lawson M
        • Kirchner P
        • Valk P
        • Karis J
        • Hubner K
        • Delbeke D
        • Heiberg EV
        • Path EF
        • Coleman RE
        Prospective investigation of positron emission tomography in lung nodules.
        J Clin Oncol. 1998; 16: 1075-1084
        • Lewis PJ
        • Salama A
        Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
        J Nucl Med. 1994; 35: 1647-1649
        • Coleman RE
        PET in lung cancer.
        J Nucl Med. 1999; 40: 814-820
        • Elstrom R
        • Guan L
        • Baker G
        • Nakhoda K
        • Vergilio JA
        • Zhuang H
        • Pitsilos S
        • Bagg A
        • Downs L
        • Mehrotra A
        • Kim S
        • Alavi A
        • Schuster SJ
        Utility of FDG-PET scanning in lymphoma by WHO classification.
        Blood. 2003; 101: 3875-3876
        • Yasuda S
        • Shohtsu A
        • Ide M
        • Takagi S
        • Ogawa J
        • Mitomi T
        • Suzuki Y
        High fluorine-18 labeled deoxyglucose uptake in sarcoidosis.
        Clin Nucl Med. 1996; 21: 983-984
        • Yamada Y
        • Uchida Y
        • Tatsumi K
        • Yamaguchi T
        • Kimura H
        • Kitahara H
        • Kuriyama T
        Fluorine-18-fluorodeoxygenase and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.
        J Nucl Med. 1998; 39: 1160-1166
        • de Hemricourt E
        • De Boeck K
        • Hilte F
        • Abib A
        • Kockx M
        • Vandevivere J
        • De Bock R
        Sarcoidosis and sarcoid-like reaction following Hodgkin's disease. Report of two cases.
        Mol Imaging Biol. 2003; 5: 15-19
        • Komacker M
        • Kraemer A
        • Leo E
        • Ho AD
        Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.
        Ann Hematol. 2002; 81: 103-105
        • Maeda J
        • Ohta M
        • Hirabayashi H
        • Matsuda H
        False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer.
        Jpn J Thorac Cardiovasc Surg. 2005; 53: 196-198
        • Brudin LH
        • Valind SO
        • Rhodes CG
        • Rhodes CG
        • Pantin CF
        • Sweatman M
        • Jones T
        • Hughes JM
        Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography.
        Eur J Nucl Med. 1994; 21: 297-305
        • Prenzel KL
        • Monig SP
        • Sinning JM
        • Baldus SE
        • Brochhagen HG
        • Schneider PM
        • Holscher AH
        Lymph node size and metastatic infiltration in non-small cell lung cancer.
        Chest. 2003; 123: 463-467
        • Seam P
        • Juweid ME
        • Cheson BD
        The role of FDG-PET scans in patients with lymphoma.
        Blood. 2007; 110: 3507-3516